Page last updated: 2024-08-21

thiazolidine-4-carboxylic acid and Malignant Melanoma

thiazolidine-4-carboxylic acid has been researched along with Malignant Melanoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, Y; Li, F; Li, Y; Wang, J; Zhang, J; Zhang, S1
Bassleer, R; Desaive, C; Jamoulle, JC; Lapiere, CL; Marnette, JM; Wiliquet, P1

Other Studies

2 other study(ies) available for thiazolidine-4-carboxylic acid and Malignant Melanoma

ArticleYear
Structural analysis for colchicine binding site-targeted ATCAA derivatives as melanoma antagonists.
    Medicinal chemistry (Shariqah (United Arab Emirates)), 2014, Volume: 10, Issue:3

    Topics: Amides; Binding Sites; Colchicine; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Melanoma; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; Skin Neoplasms; Thiazolidines

2014
[New research on the cellular effects of thiaproline].
    Annales pharmaceutiques francaises, 1983, Volume: 41, Issue:6

    Topics: Animals; Antineoplastic Agents; Female; Humans; Male; Melanoma; Mice; Mice, Inbred C57BL; Mitosis; Thiazoles; Thiazolidines

1983